Skip to content

Rational Use of Personal Protective Equipment During COVID-19 Pandemic

Rational Use of Personal Protective Equipment: a Randomised Trial and Quality Improvement Intervention During COVID-19 Pandemic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04712045
Acronym
RUPERT
Enrollment
67
Registered
2021-01-15
Start date
2020-08-01
Completion date
2020-12-12
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Personal Protective Equipment

Keywords

PPE, Multi-drug resistance organism, Cross-infection

Brief summary

This study aims to improve the personal protective equipment (PPE) used while treating patients with COVID-19, to protect staff and avoid cross-infection of patients. Protecting staff from infection during the Covid pandemic is critical to maintaining health services. Mistakes in using protective equipment (PPE) are the commonest avoidable factor in staff becoming infected at work. Recently, intensive care doctors have also reported an increase in the spread of dangerous multi-resistant bacteria between patients, which appears likely to be transmitted between patients by Level 2 PPE worn by staff (specifically gown sleeves). This study therefore seeks to develop and test a new protocol to decrease cross-infection risks whilst using Level 2 PPE.

Interventions

OTHERNew PPE

The use of a new protocol of level 2 PPE which involves wearing a short-sleeve gown and a single pair of gloves

OTHEROld PPE

The use of a standard protocol of level 2 PPE which involves wearing a long-sleeve gown and double pairs of gloves

Sponsors

University of Oxford
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. NHS staff and works in the Adult Intensive Care Unit, Neuro Intensive Care Unit or Cardio-thoracic Intensive Care Unit 2. Trained in the correct use of Level 2 PPE according to current guidance 3. Trained in ICU COVID19 Intubation and Proning protocols 4. Willing and able to give informed consent for participation in the study.

Exclusion criteria

1\. taking any medication which can cause photosensitivity reactions in the preceding 3 months

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants and simulated patients with contamination as assessed by ultraviolet lightimmediately after simulationsThe primary outcome of this study is the proportion of participants and simulated patients who were contaminated with fluorescent powder as examined under a UV light, using a response of YES or NO, when participants wore new (experimental) Level 2 PPE in comparison to the standard (control) Level 2 PPE

Secondary

MeasureTime frameDescription
Participants' perception of personal comfort and safety and safety of the patients as assessed through structured questionnaireimmediately before simulations and immediately after simulationsWe will measure the participants' perception of personal comfort and safety and the safety of the patient when wearing experimental versus control Level 2 PPE, during simulation tasks, using a 10 point Likert scale response to a structured questionnaire
changes in participants perception of personal comfort and safety and safety of patients as assessed through a semi-structured questionnaireimmediately before training, immediately after training and immediately after simulationWe will measure changes in participants perception of their personal comfort and safety and the safety of patients when wearing each type of PPE using a semi-structured interview (a) before the PPE training, (b) after the PPE training, and (c) after the simulation training exercises.
The difference in the area of contamination between New and Standard PPE as analyzed through python scriptimmediately after simulationswe will perform a quantitative analysis of the area of contamination of participants and simulated patients and assess the difference between when participants wore new (experimental) Level 2 PPE and the standard (control) Level 2 PPE, using pre-coded functions with python script.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026